Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polygon Global Partners is a global alternative investment and asset management firm rather than a life sciences, biotech, pharma, or healthcare operating company. The firm manages hedge fund and private investment strategies across areas such as convertible securities, event-driven investing, equities, and restructuring-related opportunities. Publicly available sources indicate it was established in 2002 and has been associated with Tetragon's asset management platform. Because it is a financial services business and not a therapeutic developer, it does not have a drug pipeline, clinical programs, therapeutic targets, or healthcare products and services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polygon Global Partners.